Coxsackie Remedy (Deseret Biologicals, Inc.)


Welcome to the PulseAid listing for the Coxsackie Remedy drug offered from Deseret Biologicals, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Deseret Biologicals, Inc.
NON-PROPRIETARY NAME: Coxsackie Nosode A2, A7, B1, B3, B4
SUBSTANCE NAME: HUMAN COXSACKIEVIRUS A2; HUMAN COXSACKIEVIRUS A7; HUMAN COXSACKIEVIRUS B1; HUMAN COXSACKIEVIRUS B3; HUMAN COXSACKIEVIRUS B4
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2015-09-23
END MARKETING DATE: 2020-10-13


Coxsackie Remedy HUMAN OTC DRUG Details:

Item DescriptionCoxsackie Remedy from Deseret Biologicals, Inc.
LABELER NAME: Deseret Biologicals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 7; 7; 7; 7; 7([hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL)
START MARKETING DATE: 2015-09-23
END MARKETING DATE: 2020-10-13
PRODUCT ID: 43742-0634_3c553420-c163-49a4-9257-1b4bd062af9d
PRODUCT NDC: 43742-0634
APPLICATION NUMBER:

Other HUMAN COXSACKIEVIRUS A2; HUMAN COXSACKIEVIRUS A7; HUMAN COXSACKIEVIRUS B1; HUMAN COXSACKIEVIRUS B3; HUMAN COXSACKIEVIRUS B4 Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Deseret Biologicals, Inc.Coxsackie Homochord